about
Epigenetic alterations in chronic disease focusing on Behçet's disease: Review.Chrysin Alters microRNAs Expression Levels in Gastric Cancer Cells: Possible Molecular Mechanism.Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer CellsSilibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells.The emu oil emulsified in egg lecithin and butylated hydroxytoluene enhanced the proliferation, stemness gene expression, and in vitro wound healing of adipose-derived stem cells.Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells.Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial.A Biomimetic Emu Oil-Blended Electrospun Nanofibrous Mat for Maintaining Stemness of Adipose Tissue-Derived Stem Cells.Assessing the Effect of High Performance Inulin Supplementation via KLF5 mRNA Expression in Adults with Type 2 Diabetes: A Randomized Placebo Controlled Clinical Trail.Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's diseaseDetermination of mir-155 and mir-146a expression rates and its association with expression level of TNF-α and CTLA4 genes in patients with Behcet's diseaseInduces Apoptosis via Gene Expression in Pancreatic Cancer CellsHypermethylation of IL-10 gene is responsible for its low mRNA expression in Behçet's diseaseEvaluation of SOCS1 methylation in patients with Behcet's diseaseMethylation Status of Interleukin-6 Gene Promoter in Patients with Behçet's DiseaseThe MicroRNA-326: Autoimmune diseases, diagnostic biomarker, and therapeutic targetPromoter methylation of Bax and Bcl2 genes and their expression in patients with Behcet's disease
P50
Q36365909-0572DC6D-B983-4C0E-945F-041AE8117396Q38699828-02763984-BA7F-470F-B729-B1EE569AAFEBQ38700449-3845D6E9-872B-4941-A5C1-EBB3673FBDF2Q38721741-7551D0DF-5230-4F7D-96FC-3FD1F950A2B8Q49587991-50A0B19D-14DE-4A7F-9BE6-93345D0A6D08Q50224155-14CAD811-690A-42E2-B79E-77388587A019Q51253872-ABD4F0A5-116B-4C52-8CD9-BA2F5582C9D1Q51746224-59EA82B1-DA22-4BBC-8958-D41BCCFE9E01Q55076089-39DD29A3-880E-490A-BB1D-BE06FC6796CCQ57467249-496B304C-33DF-411C-B266-C86E3C09EB50Q58574493-B502A500-77F2-4FFE-B9B6-C595AFAD3A66Q60925861-94B930DF-608C-4AB4-87A7-33DBE4F8F752Q88543584-44F919C7-A68B-4A73-AEBB-8C766A85EE47Q89499247-FF7CE490-E1BB-4D18-A7EA-D2F5C104B2D0Q90745626-E1851EA2-EB4B-4682-A5F7-23B74B07D4C8Q90758513-AECEB508-A2EF-4AAB-8FCB-46DC8E04A130Q92509829-B076A49B-F38B-418F-A9BB-6E24873CABC2
P50
description
researcher ORCID ID = 0000-0002-2202-9598
@en
name
Shahriar Alipour
@ast
Shahriar Alipour
@en
Shahriar Alipour
@es
Shahriar Alipour
@nl
type
label
Shahriar Alipour
@ast
Shahriar Alipour
@en
Shahriar Alipour
@es
Shahriar Alipour
@nl
prefLabel
Shahriar Alipour
@ast
Shahriar Alipour
@en
Shahriar Alipour
@es
Shahriar Alipour
@nl
P1153
57192937149
P31
P496
0000-0002-2202-9598